LabCompass

Corena V. Grant

Medicine · The Ohio State University

OpenAlex ORCID
Established · publishing since 1971
Cancer-related cognitive impairment studiesCancer, Stress, Anesthesia, and Immune ResponseNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersGut microbiota and health

Publications

32

Citations

317

Est. group size

~11

Recurring co-author estimate

Active years

54

Publishing since 1971

Research summary
AI-generated

Corena V. Grant's work spans two connected areas: how chemotherapy drugs (like paclitaxel) affect behavior, metabolism, and gut bacteria in mice, and how natural compounds might selectively target triple-negative breast cancer cells. Recent outputs include shared datasets and figures on antibiotic-chemotherapy interactions alongside earlier studies identifying cancer-cell vulnerabilities using genetic screening tools like CRISPR.

Chemotherapy side effects and behaviorGut microbiome and drug interactionsTriple-negative breast cancer biologyNatural compound drug discoveryCancer-related cognitive and activity impairment

Publication output grew from none in 2017-2018 to a peak in 2022, followed by a decline through 2023-2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.2/year recently
17182019: 3 publications192020: 2 publications202021: 5 publications212022: 12 publications12222023: 6 publications232024: 3 publications242526
Recent publications
Publishes in
  • Brain Behavior and Immunity×10
  • Figshare×7
  • Breast Cancer Research and Treatment×1
  • BMC Cancer×1
  • Behavioural Brain Research×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile